Corrigendum to "Long non-coding RNAs and exosomal lncRNAs: potential functions in lung cancer progression, drug resistance and tumor microenvironment remodeling"(Biomedicine & Pharmacotherapy, (2022), 150, C, (112963), (S0753332222003523), 10.1016/j.biopha.2022.112963)

Official URL: https://dx.doi.org/10.1016/j.biopha.2026.119309

This Corrigendum relates to the above article. In this article, the authors have included Ref. [225] and [312] that require correction due to contextual inappropriateness: [225]: S. Mirzaei, et al. Small interfering RNA (siRNA) to target genes and molecular pathways in glioblastoma therapy: current status with an emphasis on delivery systems. Life Sci. (2021), Article 119368 [312]: M. Ashrafizade, et al. Biomedical application of chitosan-based nanoscale delivery systems: potential usefulness in siRNA delivery for cancer therapy. Carbohydr. Polym. (2021), Article 117809 The authors confirm that these references were inadvertently introduced in the article. Refs. [225] and [312] should be considered as removed from the reference list and their intext citations ignored. The updated references for [225] and [312] should be as below: [225]: Ma J, Miao H, Zhang H, Ren J, Qu S, Da J, Xu F, Zhao H. LncRNA GAS5 modulates the progression of non-small cell lung cancer through repressing miR-221-3p and up-regulating IRF2. Diagnostic Pathology. 2021 May 22;16(1):46. [312]: Liang Y, Rong X, Luo Y, Li P, Han Q, Wei L, Wang E. A novel long non-coding RNA LINC00355 promotes proliferation of lung adenocarcinoma cells by down-regulating miR-195 and up-regulating the expression of CCNE1. Cellular Signalling. 2020 Feb 1;66:109462. The authors apologise for the errors.